1311 related articles for article (PubMed ID: 26752109)
1. Histamine Receptor H1-Mediated Sensitization of TRPV1 Mediates Visceral Hypersensitivity and Symptoms in Patients With Irritable Bowel Syndrome.
Wouters MM; Balemans D; Van Wanrooy S; Dooley J; Cibert-Goton V; Alpizar YA; Valdez-Morales EE; Nasser Y; Van Veldhoven PP; Vanbrabant W; Van der Merwe S; Mols R; Ghesquière B; Cirillo C; Kortekaas I; Carmeliet P; Peetermans WE; Vermeire S; Rutgeerts P; Augustijns P; Hellings PW; Belmans A; Vanner S; Bulmer DC; Talavera K; Vanden Berghe P; Liston A; Boeckxstaens GE
Gastroenterology; 2016 Apr; 150(4):875-87.e9. PubMed ID: 26752109
[TBL] [Abstract][Full Text] [Related]
2. Sensitivity testing in irritable bowel syndrome with rectal capsaicin stimulations: role of TRPV1 upregulation and sensitization in visceral hypersensitivity?
van Wanrooij SJ; Wouters MM; Van Oudenhove L; Vanbrabant W; Mondelaers S; Kollmann P; Kreutz F; Schemann M; Boeckxstaens GE
Am J Gastroenterol; 2014 Jan; 109(1):99-109. PubMed ID: 24189713
[TBL] [Abstract][Full Text] [Related]
3. Quantification and Potential Functions of Endogenous Agonists of Transient Receptor Potential Channels in Patients With Irritable Bowel Syndrome.
Cenac N; Bautzova T; Le Faouder P; Veldhuis NA; Poole DP; Rolland C; Bertrand J; Liedtke W; Dubourdeau M; Bertrand-Michel J; Zecchi L; Stanghellini V; Bunnett NW; Barbara G; Vergnolle N
Gastroenterology; 2015 Aug; 149(2):433-44.e7. PubMed ID: 25911511
[TBL] [Abstract][Full Text] [Related]
4. Histamine-mediated potentiation of transient receptor potential (TRP) ankyrin 1 and TRP vanilloid 4 signaling in submucosal neurons in patients with irritable bowel syndrome.
Balemans D; Aguilera-Lizarraga J; Florens MV; Jain P; Denadai-Souza A; Viola MF; Alpizar YA; Van Der Merwe S; Vanden Berghe P; Talavera K; Vanner S; Wouters MM; Boeckxstaens GE
Am J Physiol Gastrointest Liver Physiol; 2019 Mar; 316(3):G338-G349. PubMed ID: 30629470
[TBL] [Abstract][Full Text] [Related]
5. Effect of resolvins on sensitisation of TRPV1 and visceral hypersensitivity in IBS.
Perna E; Aguilera-Lizarraga J; Florens MV; Jain P; Theofanous SA; Hanning N; De Man JG; Berg M; De Winter B; Alpizar YA; Talavera K; Vanden Berghe P; Wouters M; Boeckxstaens G
Gut; 2021 Jul; 70(7):1275-1286. PubMed ID: 33023902
[TBL] [Abstract][Full Text] [Related]
6. Treatment of non-constipated irritable bowel syndrome with the histamine 1 receptor antagonist ebastine: a randomised, double-blind, placebo-controlled trial.
Decraecker L; De Looze D; Hirsch DP; De Schepper H; Arts J; Caenepeel P; Bredenoord AJ; Kolkman J; Bellens K; Van Beek K; Pia F; Peetermans W; Vanuytsel T; Denadai-Souza A; Belmans A; Boeckxstaens G
Gut; 2024 Feb; 73(3):459-469. PubMed ID: 38191268
[TBL] [Abstract][Full Text] [Related]
7. Comparison of inhibition of cutaneous histamine reaction of ebastine fast-dissolving tablet (20 mg) versus desloratadine capsule (5 mg): a randomized, double-blind, double-dummy, placebo-controlled, three-period crossover study in healthy, nonatopic adults.
Antonijoan R; García-Gea C; Puntes M; Pérez J; Esbrí R; Serra C; Fortea J; Barbanoj MJ
Clin Ther; 2007 May; 29(5):814-822. PubMed ID: 17697901
[TBL] [Abstract][Full Text] [Related]
8. Histamine induces peripheral and central hypersensitivity to bladder distension via the histamine H
Grundy L; Caldwell A; Garcia Caraballo S; Erickson A; Schober G; Castro J; Harrington AM; Brierley SM
Am J Physiol Renal Physiol; 2020 Feb; 318(2):F298-F314. PubMed ID: 31790304
[TBL] [Abstract][Full Text] [Related]
9. Alterations in mucosal neuropeptides in patients with irritable bowel syndrome and ulcerative colitis in remission: a role in pain symptom generation?
Keszthelyi D; Troost FJ; Jonkers DM; Helyes Z; Hamer HM; Ludidi S; Vanhoutvin S; Venema K; Dekker J; Szolcsányi J; Masclee AA
Eur J Pain; 2013 Oct; 17(9):1299-306. PubMed ID: 23529955
[TBL] [Abstract][Full Text] [Related]
10. A comparison of ebastine 10 mg fast-dissolving tablet with oral desloratadine and placebo in inhibiting the cutaneous reaction to histamine in healthy adults.
Antonijoan RM; García-Gea C; Puntes M; Valle M; Esbri R; Fortea J; Barbanoj MJ
Clin Drug Investig; 2007; 27(7):453-61. PubMed ID: 17563125
[TBL] [Abstract][Full Text] [Related]
11. Activation of human enteric neurons by supernatants of colonic biopsy specimens from patients with irritable bowel syndrome.
Buhner S; Li Q; Vignali S; Barbara G; De Giorgio R; Stanghellini V; Cremon C; Zeller F; Langer R; Daniel H; Michel K; Schemann M
Gastroenterology; 2009 Oct; 137(4):1425-34. PubMed ID: 19596012
[TBL] [Abstract][Full Text] [Related]
12. Increased capsaicin receptor TRPV1-expressing sensory fibres in irritable bowel syndrome and their correlation with abdominal pain.
Akbar A; Yiangou Y; Facer P; Walters JR; Anand P; Ghosh S
Gut; 2008 Jul; 57(7):923-9. PubMed ID: 18252749
[TBL] [Abstract][Full Text] [Related]
13. Randomized clinical trial on the effect of a multispecies probiotic on visceroperception in hypersensitive IBS patients.
Ludidi S; Jonkers DM; Koning CJ; Kruimel JW; Mulder L; van der Vaart IB; Conchillo JM; Masclee AA
Neurogastroenterol Motil; 2014 May; 26(5):705-14. PubMed ID: 24588932
[TBL] [Abstract][Full Text] [Related]
14. Antinociceptive Effect of Ghrelin in a Rat Model of Irritable Bowel Syndrome Involves TRPV1/Opioid Systems.
Mao Y; Li Z; Chen K; Yu H; Zhang S; Jiang M; Ma Y; Liang C; Liu H; Li H; Hua Q; Zhou H; Sun Y; Fan X
Cell Physiol Biochem; 2017; 43(2):518-530. PubMed ID: 28930716
[TBL] [Abstract][Full Text] [Related]
15. Symptom severity but not psychopathology predicts visceral hypersensitivity in irritable bowel syndrome.
van der Veek PP; Van Rood YR; Masclee AA
Clin Gastroenterol Hepatol; 2008 Mar; 6(3):321-8. PubMed ID: 18258487
[TBL] [Abstract][Full Text] [Related]
16. Visceral hypersensitivity in irritable bowel syndrome.
Kanazawa M; Hongo M; Fukudo S
J Gastroenterol Hepatol; 2011 Apr; 26 Suppl 3():119-21. PubMed ID: 21443723
[TBL] [Abstract][Full Text] [Related]
17. Curcumin and Fennel Essential Oil Improve Symptoms and Quality of Life in Patients with Irritable Bowel Syndrome.
Portincasa P; Bonfrate L; Scribano ML; Kohn A; Caporaso N; Festi D; Campanale MC; Di Rienzo T; Guarino M; Taddia M; Fogli MV; Grimaldi M; Gasbarrini A
J Gastrointestin Liver Dis; 2016 Jun; 25(2):151-7. PubMed ID: 27308645
[TBL] [Abstract][Full Text] [Related]
18. Miltefosine treatment reduces visceral hypersensitivity in a rat model for irritable bowel syndrome via multiple mechanisms.
Botschuijver S; van Diest SA; van Thiel IAM; Saia RS; Strik AS; Yu Z; Maria-Ferreira D; Welting O; Keszthelyi D; Jennings G; Heinsbroek SEM; Elferink RPO; Schuren FHJ; de Jonge WJ; van den Wijngaard RM
Sci Rep; 2019 Aug; 9(1):12530. PubMed ID: 31467355
[TBL] [Abstract][Full Text] [Related]
19. Expression of the TRPV1 receptor differs in quiescent inflammatory bowel disease with or without abdominal pain.
Akbar A; Yiangou Y; Facer P; Brydon WG; Walters JR; Anand P; Ghosh S
Gut; 2010 Jun; 59(6):767-74. PubMed ID: 20551462
[TBL] [Abstract][Full Text] [Related]
20. P2Y1, P2Y2, and TRPV1 Receptors Are Increased in Diarrhea-Predominant Irritable Bowel Syndrome and P2Y2 Correlates with Abdominal Pain.
Luo Y; Feng C; Wu J; Wu Y; Liu D; Wu J; Dai F; Zhang J
Dig Dis Sci; 2016 Oct; 61(10):2878-2886. PubMed ID: 27250983
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
